Tap Consulting, LLC West Pharmaceutical Services Inc Transaction History

Tap Consulting, LLC

$487 Million
Q3 2024

A detailed history of Tap Consulting, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Tap Consulting, LLC holds 10,076 shares of WST stock, worth $3.37 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

10,076

Previous 7,669 31.39%

Holding current value

$3.37 Million

Previous $2.53 Million 19.71%

% of portfolio

0.62%

Previous 0.55%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$277.16 - $333.3 $667,124 - $802,253	2,407 Added 31.39%	10,076 $3.02 Million
Q2 2024 Aug 06, 2024	SELL	$314.68 - $395.94 $48,146 - $60,578	-153 Reduced 1.96%	7,669 $2.53 Million
Q1 2024 Apr 22, 2024	BUY	$338.27 - $413.0 $448,207 - $547,225	1,325 Added 20.39%	7,822 $3.1 Million
Q4 2023 Feb 02, 2024	SELL	$318.29 - $392.21 $23,553 - $29,023	-74 Reduced 1.13%	6,497 $2.29 Million
Q3 2023 Dec 05, 2023	SELL	$354.9 - $412.41 $614,686 - $714,294	-1,732 Reduced 20.86%	6,571 $2.47 Million
Q2 2023 Jul 19, 2023	SELL	$334.63 - $382.47 $508,302 - $580,971	-1,519 Reduced 15.47%	8,303 $3.18 Million
Q1 2023 Apr 18, 2023	SELL	$232.5 - $346.47 $467,325 - $696,404	-2,010 Reduced 16.99%	9,822 $3.4 Million
Q4 2022 Jan 23, 2023	SELL	$209.34 - $261.61 $226,505 - $283,062	-1,082 Reduced 8.38%	11,832 $0
Q3 2022 Oct 12, 2022	BUY	$246.08 - $343.65 $183,083 - $255,675	744 Added 6.11%	12,914 $3.18 Million
Q2 2022 Jul 26, 2022	SELL	$280.61 - $420.45 $1.24 Million - $1.85 Million	-4,409 Reduced 26.59%	12,170 $3.68 Million
Q1 2022 Apr 26, 2022	BUY	$357.49 - $445.92 $548,747 - $684,487	1,535 Added 10.2%	16,579 $6.81 Million
Q4 2021 Jan 27, 2022	BUY	$402.25 - $471.34 $261,864 - $306,842	651 Added 4.52%	15,044 $7.06 Million
Q3 2021 Nov 03, 2021	SELL	$363.01 - $468.47 $335,784 - $433,334	-925 Reduced 6.04%	14,393 $6.11 Million
Q2 2021 Aug 06, 2021	BUY	$284.77 - $363.2 $82,013 - $104,601	288 Added 1.92%	15,318 $5.5 Million
Q1 2021 May 12, 2021	BUY	$257.29 - $307.53 $41,423 - $49,512	161 Added 1.08%	15,030 $4.24 Million
Q4 2020 Jan 19, 2021	SELL	$261.16 - $301.66 $415,766 - $480,242	-1,592 Reduced 9.67%	14,869 $4.21 Million
Q3 2020 Oct 20, 2020	SELL	$224.99 - $288.02 $459,654 - $588,424	-2,043 Reduced 11.04%	16,461 $4.53 Million
Q2 2020 Aug 11, 2020	SELL	$149.8 - $227.17 $307,539 - $466,380	-2,053 Reduced 9.99%	18,504 $4.2 Million
Q1 2020 Apr 29, 2020	BUY	$128.96 - $174.76 $137,858 - $186,818	1,069 Added 5.49%	20,557 $3.13 Million
Q4 2019 Jan 27, 2020	BUY	$137.6 - $151.21 $216,857 - $238,306	1,576 Added 8.8%	19,488 $2.93 Million
Q3 2019 Nov 08, 2019	BUY	$121.41 - $150.02 $115,582 - $142,819	952 Added 5.61%	17,912 $2.54 Million
Q1 2019 May 03, 2019	BUY	$94.53 - $110.2 $1.6 Million - $1.87 Million	16,960 New	16,960 $1.87 Million

Others Institutions Holding WST

# of Institutions

803

Shares Held

64.4M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.

Account

Tap Consulting, LLC West Pharmaceutical Services Inc Transaction History